Extension complements pharmaceutical’s total lab solutions portfolio.
Roche has announced an expansion of its long-term alliance with Sysmex. As part of the renewed agreement, Roche is expected to continue offering Sysmex' hematology products. According to a company press release, the updated agreement also includes a new area of collaboration with an additional eco-social agreement to jointly explore more sustainable diagnostic solutions.
"We are delighted to expand our 25-year partnership with Sysmex in the area of hematology and in exploring more sustainable diagnostics solutions. Roche and Sysmex both have a long-standing history of delivering reliable and innovative solutions for patients and I am very happy to see this collaboration grow," said Matt Sause, CEO of Roche Diagnostics.
Reference: Roche expands long-term alliance with Sysmex. PR Newswire. August 3, 2023. Accessed August 7, 2023. https://www.prnewswire.com/news-releases/roche-expands-long-term-alliance-with-sysmex-301892152.html
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.